StreetInsider.com News Articles

Dentsply Sirona names John Fortson as chief financial officer

Thu, 11 Jun 2026 08:30:13 -0400

Dentsply Sirona Inc. (NASDAQ: XRAY) announced the appointment of John Fortson as executive vice president and chief financial officer, effective July 20.

Fortson brings more than 25 years of leadership experience in finance, operations, and strategy across public and private equity-backed companies. He has served 13 years as either CFO or CEO of global manufacturing and industrial businesses.

Most recently, Fortson served as president and CFO of Kymera International, a specialty materials company backed by Palladium Equity Partners and Goldman Sachs. During his tenure, he helped lead the integration of a global platform spanning 21 manufacturing facilities across 14 countries while overseeing

Dentsply Sirona names John Fortson as chief financial officer

Thu, 11 Jun 2026 08:30:13 -0400

Dentsply Sirona Inc. (NASDAQ: XRAY) announced the appointment of John Fortson as executive vice president and chief financial officer, effective July 20.

Dentsply Sirona Appoints John Fortson as Chief Financial Officer

Thu, 11 Jun 2026 08:30:00 -0400

Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses

CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of John Fortson as Executive Vice President (EVP) and Chief Financial Officer (CFO), effective July 20.

Mr. Fortson joins Dentsply Sirona with more than 25 years of leadership experience in finance, operations, and strategy across both public and private equity-backed companies. He has served for 13 years as

Dentsply Sirona Appoints John Fortson as Chief Financial Officer

Thu, 11 Jun 2026 08:30:00 -0400

Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses

Dentsply Sirona Appoints John Fortson as Chief Financial Officer

Thu, 11 Jun 2026 08:30:00 -0400

Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses

Dentsply Sirona Appoints John Fortson as Chief Financial Officer

Thu, 11 Jun 2026 08:30:00 -0400

Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses

Ingevity CEO Dave Li and CFO Phillip Platt to speak at 2026 Wells Fargo Industrials & Materials Conference

Tue, 09 Jun 2026 17:21:00 -0400

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- Ingevity Corporation (NYSE: NGVT) today announced that Dave Li, president and CEO, and Phillip Platt, senior vice president and CFO, will participate in a fireside chat during the 2026 Wells Fargo 16th Annual Industrials & Materials Conference on Thursday, June 11, at 10:30 a.m. ET.

Ingevity invites investors and interested parties to access the live webcast via the following link: Industry & Materials Industry Conference - Wells Fargo. An audio replay and transcript will be available following the event on the Events and Presentations section of Ingevity’s investor relations

Ingevity CEO Dave Li and CFO Phillip Platt to speak at 2026 Wells Fargo Industrials & Materials Conference

Tue, 09 Jun 2026 17:21:00 -0400

Ingevity CEO Dave Li and CFO Phillip Platt to speak at 2026 Wells Fargo Industrials & Materials Conference

Tue, 09 Jun 2026 17:21:00 -0400

Ingevity CEO Dave Li and CFO Phillip Platt to speak at 2026 Wells Fargo Industrials & Materials Conference

Tue, 09 Jun 2026 17:21:00 -0400

Form 4 Ingevity Corp For: May 28 Filed by: DYER TERRANCE M

Mon, 01 Jun 2026 14:04:00 -0400

si-local-file:///var/storage/secattach/20260601/26582595.html

Form 4 Ingevity Corp For: May 28 Filed by: DYER TERRANCE M

Mon, 01 Jun 2026 14:04:00 -0400

si-local-file:///var/storage/secattach/20260601/26582595.html

Form SCHEDULE 13G/A Ingevity Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP

Fri, 15 May 2026 07:35:00 -0400

si-local-file:///var/storage/secattach/20260515/26499525.html

Form SCHEDULE 13G/A Ingevity Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP

Fri, 15 May 2026 07:35:00 -0400

si-local-file:///var/storage/secattach/20260515/26499525.html

Ingevity Corp (NGVT) PT Raised to $85 at BMO Capital

Fri, 08 May 2026 09:38:54 -0400

BMO Capital analyst John McNulty raised the price target on Ingevity Corp (NYSE: NGVT) to $85.00 (from $83.00) while maintaining a Outperform rating.

Form S-8 Ingevity Corp

Thu, 07 May 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260507/26455153.html

Form S-8 Ingevity Corp

Thu, 07 May 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260507/26455153.html

Form 10-Q Ingevity Corp For: Mar 31

Thu, 07 May 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260507/26454157.html

Form 10-Q Ingevity Corp For: Mar 31

Thu, 07 May 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260507/26454157.html

Ingevity (NGVT) Tops Q1 EPS by 32c, provides guidance

Wed, 06 May 2026 16:43:59 -0400

Ingevity (NYSE: NGVT) reported Q1 EPS of $1.15, $0.32 better than the analyst estimate of $0.83. Revenue for the quarter came in at $258 million versus the consensus estimate of $279 million.

GUIDANCE:

Ingevity sees FY2026 EPS of $4.70-$5.20, versus the consensus of $4.80.

For earnings history and earnings-related data on Ingevity (NGVT) click here.

Ingevity (NGVT) Tops Q1 EPS by 32c, provides guidance

Wed, 06 May 2026 16:43:59 -0400

Ingevity (NYSE: NGVT) reported Q1 EPS of $1.15, $0.32 better than the analyst estimate of $0.83. Revenue for the quarter came in at $258 million versus the consensus estimate of $279 million.

GUIDANCE:

Ingevity sees FY2026 EPS of $4.70-$5.20, versus the consensus of $4.80.

For earnings history and earnings-related data on Ingevity (NGVT) click here.

Form 8-K Ingevity Corp For: May 06

Wed, 06 May 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260506/26444768.html

Form 8-K Ingevity Corp For: May 06

Wed, 06 May 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260506/26444768.html

Ingevity reports first quarter 2026 financial results

Wed, 06 May 2026 16:15:00 -0400

First Quarter 2026 Results & Recent Highlights:

Net sales of $258.0 million increased 4% from prior year
Net income from continuing operations of $23.4 million and $0.65 per diluted share compared to $29.1 million and $0.79 in the prior year
Adjusted earnings from continuing operations of $41.4 million and $1.15 of diluted earnings per share compared to $37.0 million and $1.01 in the prior year
Adjusted EBITDA from continuing operations of $91.5 million, flat to prior year; Adjusted EBITDA margin of 35.5% compared to 36.8% in the prior year
Completed sale of North Charleston refinery assets and the majority of Performance Chemicals Industrial Specialties

Ingevity reports first quarter 2026 financial results

Wed, 06 May 2026 16:15:00 -0400

First Quarter 2026 Results & Recent Highlights:

Net sales of $258.0 million increased 4% from prior year
Net income from continuing operations of $23.4 million and $0.65 per diluted share compared to $29.1 million and $0.79 in the prior year
Adjusted earnings from continuing operations of $41.4 million and $1.15 of diluted earnings per share compared to $37.0 million and $1.01 in the prior year
Adjusted EBITDA from continuing operations of $91.5 million, flat to prior year; Adjusted EBITDA margin of 35.5% compared to 36.8% in the prior year
Completed sale of North Charleston refinery assets and the majority of Performance Chemicals Industrial Specialties